KaloBios in free fall after pricing offering at big discount

|About: KaloBios Pharmaceuticals (KBIO)|By:, SA News Editor

KaloBios Pharmaceuticals (KBIO) slides 11% premarket on top of 15% during Wednesday's session.

The company's public offering (announced Monday) priced at just $4, nearly 37% below Tuesday's close. (8-K)